Core Viewpoint - The company has submitted an application for a transfer to the Main Board of the Hong Kong Stock Exchange, which is expected to enhance its corporate image and public recognition without issuing new shares [1] Group 1: Benefits of Main Board Listing - The company believes that the larger market capitalization, higher trading volume, and greater international recognition of the Main Board will significantly improve its corporate image and public recognition [1] - The stricter listing requirements of the Main Board are seen as a strong acknowledgment of the company's operational performance and market position [1] - The enhanced reputation is expected to improve the company's ability to attract and retain high-quality clients, business partners, and talent, while also helping to seize new business opportunities [1] Group 2: Investor Engagement and Financing - The transfer to the Main Board is anticipated to broaden the company's access to a wider range of investors, including institutional and professional investors, as well as international participants, thereby expanding and diversifying its shareholder base [1] - The company expects that the Main Board listing will enhance its financing flexibility, allowing it to obtain more diversified debt financing options under more favorable conditions [1] - This move is projected to support the optimization of the company's capital structure and provide more strategic financial management space [1] Group 3: Long-term Growth and Value Creation - The board believes that the transfer to the Main Board will have a positive impact on the company's sustainable growth and long-term development, thereby consolidating its leading position in the medical beauty sector and creating lasting value for the company and its shareholders [2]
亮晴控股拟转往主板上市